{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:19:51Z","timestamp":1788347991326,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.revmed.2022.10.385","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T09:42:15Z","timestamp":1667468535000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["L\u2019\u00e9rythroblastop\u00e9nie\u00a0: diagnostic, classification, traitement"],"prefix":"10.1016","volume":"44","author":[{"given":"Herv\u00e9","family":"Lobbes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2022.10.385_bib0310","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/asheducation-2016.1.51","article-title":"Pure red cell aplasia","volume":"2016","author":"Means","year":"2016","journal-title":"Hematology"},{"key":"10.1016\/j.revmed.2022.10.385_bib0315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.revmed.2010.07.009","article-title":"Syndromes my\u00e9lodysplasiques \u00e9rythroblastop\u00e9niques","volume":"32","author":"Martinaud","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2022.10.385_bib0320","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2141.2007.06648.x","article-title":"Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion","volume":"138","author":"Wang","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0325","first-page":"22515","article-title":"Clinicopathological associations of acquired erythroblastopenia","volume":"8","author":"Gunes","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.revmed.2022.10.385_bib0330","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2021006486","article-title":"Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2\u00a0registry databases in Japan","author":"Nakazawa","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2022.10.385_bib0335","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ejmg.2017.10.017","article-title":"Molecular approaches to diagnose Diamond-Blackfan anemia: The EuroDBA experience","volume":"61","author":"Da Costa","year":"2018","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.revmed.2022.10.385_bib0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.15701","article-title":"How I manage children with Diamond-Blackfan anaemia","volume":"184","author":"Bartels","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0345","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: cellular receptor for B19\u00a0parvovirus","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.revmed.2022.10.385_bib0350","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF00540249","article-title":"Transient erythroblastopenia of childhood. A review of 22\u00a0cases","volume":"142","author":"Gerrits","year":"1984","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.revmed.2022.10.385_bib0355","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/jcp.41.11.1242-a","article-title":"Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia","volume":"41","author":"Hamon","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0360","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0268-960X(95)90023-3","article-title":"Parvovirus B19\u00a0infection and hematopoiesis","volume":"9","author":"Brown","year":"1995","journal-title":"Blood Rev"},{"key":"10.1016\/j.revmed.2022.10.385_bib0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.revmed.2022.08.005","article-title":"Infection de l\u2019adulte \u00e0 Parvovirus","author":"Jacquot","year":"2022","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2022.10.385_bib0370","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa040528","article-title":"Pure red-cell aplasia and epoetin therapy","volume":"351","author":"Bennett","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.revmed.2022.10.385_bib0375","doi-asserted-by":"crossref","first-page":"iii33","DOI":"10.1093\/ndt\/gfh1072","article-title":"Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery","volume":"20","author":"Boven","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2022.10.385_bib0380","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMc1509362","article-title":"Immunotherapy-Associated Hemolytic Anemia with Pure Red-Cell Aplasia","volume":"374","author":"Nair","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2022.10.385_bib0385","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1634\/theoncologist.2018-0574","article-title":"Hematologic complications of immune checkpoint inhibitors","volume":"24","author":"Davis","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.revmed.2022.10.385_bib0390","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2352-3026(18)30175-3","article-title":"Haematological immune-related adverse events induced by anti-PD-1\u00a0or anti-PD-L1\u00a0immunotherapy: a descriptive observational study","volume":"6","author":"Delanoy","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0395","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/j.1875-9114.1996.tb03025.x","article-title":"Drug-induced pure red cell aplasia. pharmacotherapy","volume":"16","author":"Thompson","year":"1996","journal-title":"J Human Pharmacol Drug Therap"},{"key":"10.1016\/j.revmed.2022.10.385_bib0400","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0609.1997.tb00978.x","article-title":"Acquired pure red cell aplasia in Japan","volume":"59","author":"Mamiya","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0405","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41408-022-00632-6","article-title":"Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)","volume":"12","author":"Salama","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.revmed.2022.10.385_bib0410","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/rheumatology\/keab925","article-title":"Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90\u00a0patients","volume":"61","author":"Roussotte","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2022.10.385_bib0415","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/rheumatology\/keab363","article-title":"Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature","volume":"61","author":"Lobbes","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2022.10.385_bib0420","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V98.2.483","article-title":"Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes","volume":"98","author":"Go","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2022.10.385_bib0425","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23785","article-title":"Autoimmune cytopenias in chronic lymphocytic leukemia","volume":"89","author":"Visco","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0430","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/10428190903556394","article-title":"Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma","volume":"51","author":"Lechner","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2022.10.385_bib0435","doi-asserted-by":"crossref","first-page":"e0215021","DOI":"10.1371\/journal.pone.0215021","article-title":"Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia","volume":"14","author":"Linaburg","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2022.10.385_bib0440","first-page":"197","article-title":"Prevalence and pattern of autoimmune conditions in patients with marginal zone lymphoma: a single institution experience","volume":"79","author":"Dasanu","year":"2015","journal-title":"Conn Med"},{"key":"10.1016\/j.revmed.2022.10.385_bib0445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/ejh.13239","article-title":"Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma","volume":"103","author":"Crickx","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0450","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/bjh.14012","article-title":"Monoclonal gammopathy-associated pure red cell aplasia","volume":"173","author":"Korde","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0455","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jtho.2015.11.012","article-title":"Thymic epithelial tumor-associated cytopenia: A 10-year observational study in France","volume":"11","author":"Rivoisy","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0460","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3324\/haematol.11655","article-title":"Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group","volume":"93","author":"Hirokawa","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2022.10.385_bib0465","doi-asserted-by":"crossref","first-page":"759914","DOI":"10.3389\/fmed.2021.759914","article-title":"Pure red cell aplasia and other haematological diseases associated with thymoma: a case series and systematic review","volume":"8","author":"Yen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.revmed.2022.10.385_bib0470","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12185-019-02792-x","article-title":"Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review","volume":"111","author":"Edahiro","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0475","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.17463","article-title":"Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study","volume":"193","author":"Longval","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0480","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/bjh.12210","article-title":"Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation","volume":"160","author":"Aung","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0485","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s10875-020-00812-8","article-title":"Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2","volume":"40","author":"Le Voyer","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0490","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ajh.20660","article-title":"Myelodysplasia with erythroid hypoplasia","volume":"81","author":"Rawat","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0495","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1073\/pnas.58.2.493","article-title":"Studies on red cell aplasia I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei","volume":"58","author":"Krantz","year":"1967","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2022.10.385_bib0500","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2141.1975.tb01855.x","article-title":"Pure Red Cell Aplasia: Studies on an IgG Serum Inhibitor Neutralizing Erythropoietin","volume":"30","author":"Peschle","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0505","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood.V45.2.247.247","article-title":"Pure Red Cell Aplasia (PRCA): Response of three patients to Cyclophosphamide and\/or Anti-lymphocyte Globulin (ALG) and demonstration of two types of serum IgG Inhibitors to Erythropoiesis","volume":"45","author":"Marmont","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2022.10.385_bib0510","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM199603073341004","article-title":"Autoantibodies against Erythropoietin in a Patient with Pure Red-Cell Aplasia","volume":"334","author":"Casadevall","year":"1996","journal-title":"N Eng J Med"},{"key":"10.1016\/j.revmed.2022.10.385_bib0515","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0609.1985.tb01711.x","article-title":"Complete remission in pure red cell aplasia after plasmapheresis","volume":"35","author":"Freund","year":"1985","journal-title":"Scandinavian J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0520","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2141.1988.tb04239.x","article-title":"Demonstration of three distinct immunological disorders on erythropoiesis in a patient with pure red cell aplasia and autoimmune haemolytic anaemia associated with thymoma","volume":"68","author":"Taniguchi","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0525","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1172\/JCI110713","article-title":"T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia","volume":"70","author":"Mangan","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2022.10.385_bib0530","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2141.2010.08273.x","article-title":"correspondence: Expansion of CD8+\/perforin+ effector memory T cells in the bone marrow of patients with thymoma-associated pure red cell aplasia","volume":"150","author":"Nitta","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0535","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2141.1986.tb07495.x","article-title":"Pure red cell aplasia: lymphocyte inhibition of erythropoiesis","volume":"63","author":"Abkowitz","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0540","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/bloodadvances.2018022723","article-title":"Frequent STAT3\u00a0mutations in CD8+ T cells from patients with pure red cell aplasia","volume":"2","author":"Kawakami","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2022.10.385_bib0545","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/JCM.40.3.933-936.2002","article-title":"Prevalence of Parvovirus B19\u00a0and Parvovirus V9\u00a0DNA and antibodies in paired bone marrow and serum samples from healthy individuals","volume":"40","author":"Heegaard","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0550","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.11192","article-title":"Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group","volume":"92","author":"Sawada","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2022.10.385_bib0555","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.12871","article-title":"Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group","volume":"93","author":"Fujishima","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2022.10.385_bib0560","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/bjh.13376","article-title":"Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004\/2006\u00a0by the Japan PRCA collaborative study group","volume":"169","author":"Hirokawa","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0565","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/cis1046","article-title":"Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19\u00a0infection: a retrospective study of 10\u00a0patients and review of the literature","volume":"56","author":"Crabol","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2022.10.385_bib0570","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","article-title":"Acquired pure red cell aplasia: updated review of treatment","volume":"142","author":"Sawada","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0575","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/blood.2021010898","article-title":"manage acquired pure red cell aplasia in adults","volume":"137","author":"Gurnari","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2022.10.385_bib0580","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0002-9343(00)00406-X","article-title":"Low-dose methotrexate for the treatment of patients with large granular lymphocyte leukemia associated with rheumatoid arthritis","volume":"108","author":"Hamidou","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2022.10.385_bib0585","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0609.2008.01187.x","article-title":"Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia","volume":"82","author":"D\u2019Arena","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2022.10.385_bib0590","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3324\/haematol.2017.175810","article-title":"Rational management approach to pure red cell aplasia","volume":"103","author":"Balasubramanian","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2022.10.385_bib0595","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41375-022-01532-1","article-title":"Sirolimus is effective for refractory\/relapsed\/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial","volume":"36","author":"Huang","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2022.10.385_bib0600","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.21037\/jtd.2018.07.14","article-title":"Pure red cell aplasia associated with thymoma: a report of a single-center experience","volume":"10","author":"Moriyama","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.revmed.2022.10.385_bib0605","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2022.281398","article-title":"Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia","author":"Gangat","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2022.10.385_bib0305","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MOH.0000000000000499","article-title":"Strategies for managing transfusional iron overload: conventional treatments and novel strategies","volume":"26","author":"Sheth","year":"2019","journal-title":"Curr Opin Hematol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322010736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322010736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:27Z","timestamp":1759337187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322010736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0248866322010736"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.10.385","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L\u2019\u00e9rythroblastop\u00e9nie\u00a0: diagnostic, classification, traitement","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.10.385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}